4//SEC Filing
Gilmour Duncan 4
Accession 0001036262-22-000006
CIK 0001036262other
Filed
Mar 10, 7:00 PM ET
Accepted
Mar 11, 2:56 PM ET
Size
9.6 KB
Accession
0001036262-22-000006
Insider Transaction Report
Form 4
INTEST CORPINTT
Gilmour Duncan
CFO, Treasurer & Secretary
Transactions
- Award
Common Stock
2022-03-09+6,831→ 21,604 total - Award
Common Stock
2022-03-09+6,832→ 14,773 total - Award
Employee Stock Option (right to buy)
2022-03-09+12,848→ 12,848 totalExercise: $9.76Exp: 2032-03-08→ Common Stock (12,848 underlying)
Holdings
- 200(indirect: By Spouse)
Common Stock
Footnotes (3)
- [F1]The shares acquired are restricted shares issued pursuant to the Issuer's Third Amended and Restated 2014 Stock Plan (the "Plan") and will vest 25% annually commencing on March 9, 2023.
- [F2]The shares acquired are performance-based restricted shares issued pursuant to the Plan and will vest on March 9, 2025 dependent upon certain performance criteria. The amount shown reflects the number of shares that will vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 10,247.
- [F3]The option was issued pursuant to the Plan and will vest 25% annual commencing on March 9, 2023.
Documents
Issuer
INTEST CORP
CIK 0001036262
Entity typeother
Related Parties
1- filerCIK 0001866719
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 7:00 PM ET
- Accepted
- Mar 11, 2:56 PM ET
- Size
- 9.6 KB